June 2025 – content

Life Sciences

MaxCyte expands GCT offering with acquisition

HighRes buys dispensing expert Let’s Go Robotics

Organoid company to enhance Merck’s cell culture offering

Labviva opens European headquarters              

Standard Biotools adds to SomaLogic’s proteomics platform

Wildcat Lab to bring PulpFixin’s zero-waste lab solutions to Europe

Bruker makes majority investment in TDM specialist

Refurbished equipment provider makes second investor-backed acquisition

Qiagen opens APAC bioinformatics data centre NIB

General Laboratories

Dotmatics to be snapped up by Siemens’ DI division

Bridge12 sells EPR business to Bruker BioSpin

Foss expands manufacturing capacity with Danish site

Arquimed tops $60 million sales mark in 2024

Carlo Erba Reagents signs Th Geyer as exclusive distributor

Instrument training software company Envoke-Demos raises funds

Shimadzu opens US R&D site

Process & hand-held instrumentation

Abselion raises funds for at-line protein quantification

NDT systems manufacturer Yxlon renames

Ametek acquires specialist machining company

Food safety testing business acquires software company

Headwall signs food industry partner and makes fourth acquisition

Financials

Qiagen reports rising top lines after two weak years

Profitability still some way off in Standard Biotools’ merger year

Last quarter recovery results in enhanced forecast for Merck LS

Losses mount at Maravai as sales decline continues

Cytek grows organically in 2024

After sales stagnation, Foss reports 6% growth

Nanalysis’ service revenue doubles in 2024

Analytical instrument market stable for IDEX HST

Biotage back to organic decline in the last calendar quarter

Disposal more than offsets Q4 recovery at Avantor

No life science market recovery in sight at IMI

Delays in India hit Kewaunee’s international business

DT’s growth rate subdued on Medical sales decline

Indutrade pushed to growth by acquisitions

Comet buoyed by semiconductor market recovery

Semiconductor markets provide over half of Inficon’s 2024 sales

Getinge LS held back by weak biopharma

Appointments